baber/WOPTO huggingface dataset:
Patent NZ-592602-A (NZ)
Title: Image device with two lenses that have parallel axes and arranged so the viewing area of each lens does not overlap
Inventor: THOMSON PETER KENNETH
IPC: A63B69/06
Filed: 2009-10-02
Abstract: 592602 Disclosed is an imaging device. The device includes an array of lenses mounted onto a single body (22). The array includes at least two lenses (8, 10) that face in opposing directions so that the field of view of one lens (8) in the array does not overlap with the field of view of any other lens (10) in the array. The axes of the two lenses are fixed to be substantially parallel and the device is adapted to simultaneously capture images from the two lenses (8, 10).
Patent NZ-595942-A (NZ)
Title: Processes for the preparation of rivaroxaban and intermediates thereof
Inventor: BODHURI PRABHUDAS
IPC: A61K31/5375
Filed: 2010-04-28
Abstract: 595942 Disclosed herein is a process for the preparation of S-Rivaroxaban (1) and/or R-Rivaroxaban comprising reacting, in the presence of a first base such as a strong base suitable for deprotonation of an amide, a compound of Formula 9 with a compound of Formula 8. Additionally disclosed are intermediates useful in the preparation of S-Rivaroxaban (1) and/or R-Rivaroxaban.
Patent NZ-596028-A (NZ)
Title: Improved carbon capture in fermentation
Inventor: OAKLEY SIMON DAVID
IPC: C12P7/06
Filed: 2010-04-29
Abstract: Disclosed is a method of increasing carbon capture in a fermentation process, the method comprising gasifying a feedstock to produce a syngas substrate in a gasifier and contacting at least a portion of the syngas substrate comprising at least CO with at least one micro?organism in a bioreactor to produce at least one product, wherein at least a portion of an exit stream that exits the bioreactor is passed into the gasifier.
Patent NZ-598852-A (NZ)
Title: Protective housing to prevent eating of caught fish by predators
Inventor: SORVIK OMAR
IPC: A01K91/18
Filed: 2010-08-20
Abstract: The disclosure relates to a fishing protector (2) and a method for use of the fishing protector at or near the sea bed by long-line fishing to avoid that the catch is eaten by sea mammal when the line (3) with the catch is hauled into a fishing boat. A gliding stopper (6) is fastened at the termination of the line (3) and thereafter the fishing protector (2) is hooked on the line during the setting out of the line such that the line (3) passes through the fishing protector (2). By hauling of the line (3) the line is passing through the fishing protector (2) and the catch is hooked off inside the fishing protector (2). An opening and closing mechanism (11) at a first termination (12) of the fishing protector closes the opening (9) through which the fish passed, avoiding fish to escape. Finally, the opening (9) for receiving fish in the fishing protector (2) is closed by a gliding stopper (not shown) before the fishing protector (2) is hauled towards the surface.
Patent NZ-607674-A (NZ)
Title: Screen panel with improved apertures
Inventor: MOHANKA MADAN MOHAN
IPC: B07B1/46
Filed: 2011-03-11
Abstract: A screen panel with apertures for mining and quarrying industries adapted to be mounted on a screen deck includes a screening surface made up of deformable materials formed on a reinforcing frame. The screen panel has apertures for allowing materials to pass through. The apertures are formed by resilient ribs 5 with resilient protrusions 4 on the ribs 5 extending from opposed sides of the ribs 5 in the screening surface. Adjacent ribs 5 and protrusions 4 are configured with respect to each other such that open space exists
Patent NZ-607906-A (NZ)
Title: Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
Inventor: DEISHER THERESA
IPC: A61P35/00
Filed: 2011-08-18
Abstract: Disclosed is the use of a therapeutic agent for the manufacture of a medicament for inhibiting stem cells binding to germinal centres within lymphoid tissue in a subject suffering from a condition selected from the group consisting of: - osteopetrosis, limbal stem cell deficiency, acute myocardial infarction, coronary artery disease, peripheral vascular disease, heart failure, type I diabetes mellitus, type 2 diabetes mellitus, stroke, spinal cord injury, multiple sclerosis, systemic sclerosis, lupus erythematosus, chronic wound healing, burns, fracture healing, cartilage degeneration, connective tissue diseases, osteoarthritis, rheumatoid arthritis, renal failure, Parkinson’s Disease, myelomas, diabetic foot, liver and biliary cirrhosis, dilated cardiomyopathy, retinitis pigmentosa, Crohn’s Disease, diabetic neuropathy, mastocytosis, epilepsy, myasthenia gravis, autoimmune diseases, granulomatous disease, osteonecrosis, liver failure, PMD disease, lypodystrophy, demyelinating diseases, cartilage defects, retinal disease, lupus nephritis, Alzheimer’s Disease, traumatic brain injury, myositis, hyperglycemia, macular degeneration, ulcerative colitis, and muscle degeneration; - wherein the medicament is formulated for administration to said subject having germinal centres within their lymphoid tissue prior to or in conjunction with the stem cells; - wherein the therapeutic agent does not block the binding of stem cells to a target organ or tissue; and - wherein the therapeutic agent is an immune modulator.
Patent NZ-611916-A (NZ)
Title: Methods to determine zygosity in a bulked sample
Inventor: CHANNABASAVARADHYA CHANDRA-SHEKARA
IPC: C12Q1/68
Filed: 2011-12-28
Abstract: Disclosed is a method for determining the zygositiy of a sample of genomes for an insertion event of less than about 5 kilobases, the method comprising the following steps: - isolating genomic nucleic acid from the sample; - contacting the nucleic acid with: i) a forward primer for binding to the nucleic acid upstream of the insertion event; ii) a first reverse primer for binding to the nucleic acid of the insertion event; iii) a second reverse primer for binding to the nucleic acid downstream of the insertion event; and iv) a DNA polymerase for catalyzing a polymerase chain reaction; thereby forming a reaction sample; - providing conditions to the reaction sample enabling the formation of: i) a first PCR product in the form of a nucleic acid fragment that may be produced from the forward primer and the first reverse primer; ii) a second PCR product in the form of a nucleic acid fragment that may be produced from the forward primer and the second reverse primer and that does not contain the nucleotide sequence of the insertion event; and iii) a third PCR product in the form of a nucleic acid fragment that may be produced from the forward primer and the second reverse primer and contains the nucleotide sequence of the insertion event; - analysing the reaction sample to determine the presence of first, second and third PCR products contained therein; wherein the presence of the first and third PCR product but not the second PCR product indicates that the sample only contains genomes which comprise the insertion event; wherein the presence of the second PCR product and one or both of the first and third PCR products indicates that the sample contains at least one genome that does not have the insertion event; and wherein the presence of the second PCT product but not the first and third PCR products indicates that the sample only contains genomes which do not comprise the insertion event.
Patent NZ-614041-A (NZ)
Title: Hybrid sol-gel coated glass containers
Inventor: CLICK CAROL A
IPC: C03C25/10
Filed: 2012-02-24
Abstract: A method of coating an exterior surface of a glass container 110 that includes the steps of providing a hybrid sol-gel 15 having a solids content of greater than 90% by volume and being formed from a composition including at least one silane and at least one solvent, heating the hybrid sol-gel 15 to produce a heated hybrid sol-gel 15 having a target viscosity between 0.025 Pa•s and 0.05 Pa•s, coating an exterior glass surface of a glass container with the heated hybrid sol-gel 15, and heating the coated exterior glass surface of the glass container to cross-link the hybrid sol-gel 15 and result in a transparent coating on the exterior glass surface of the glass container having greater than 90% silicate-based material by weight.
Patent NZ-614433-A (NZ)
Title: A triboelectric x-ray source
Inventor: PUTTERMAN SETH J
IPC: H01J35/16
Filed: 2012-03-09
Abstract: Disclosed is an x-ray source (100) for generating x-rays with at least one narrow energy band. The x-ray source (100) includes an enclosing vessel (not shown), a first contact (102) arranged with a first contact surface (104) in the enclosing vessel, a second contact (106) arranged with a second contact surface (108) in the enclosing vessel, and an actuator assembly (110) operatively connected to at least one of the first (102) and second (106) contacts. The actuator assembly (110) is structured to cause the first contact surface (104) and the second contact surface (108) to repeatedly come into contact, and separate after making contact, while in operation. The first contact surface (104) is a surface of a first triboelectric material and the second contact surface (108) is a surface of a second triboelectric material; the surface of the first triboelectric material having a negative triboelectric potential relative to the surface of the second triboelectric material. The second contact (106) includes a material that includes an atomic element in its composition that has an excited quantum energy state that can be excited by electrons travelling from the first contact surface (104) to the second contact surface (108) such that the atomic element emits x-rays having an energy within the at least one narrow energy band upon transition from the excited state into a lower energy state. The enclosing vessel is structured to provide control of an atmospheric environment to which the first (104) and second (108) contact surfaces are exposed. An x-ray source for generating an array of x-rays, and formed from a plurality of the x-ray sources (100) detailed above, is also disclosed.
Patent NZ-626601-A (NZ)
Title: Wood adhesive composition comprising an isocyanate, a polyether and an amino resin
Inventor: HOLVOET SERVAAS
IPC: C08L97/02
Filed: 2013-01-08
Abstract: Disclosed is an adhesive formulation obtained by simultaneously mixing at least one isocyanate, at least one polyether and at least one amino resin, wherein said polyether comprises at least one ethylene oxide moiety and at least one isocyanate reactive group selected from the group comprising hydroxyl, amino, epoxy, and thiol, and wherein said amino resin is the condensation product of an aldehyde with a compound selected from the group comprising urea, melamine, benzoguanamine, glycoluril, and acetoguanamine (e.g., urea-formaldehyde).
Patent NZ-626947-A (NZ)
Title: Use of reduced calorie infant formula containing nucleotides and/or carotenoids for reducing adverse health effects later in life
Inventor: MARRIAGE BARBARA J
IPC: A23L33/00
Filed: 2012-12-04
Abstract: Disclosed is the use of at least one of a nucleotide at a concentration of 42 mg/L to 102 mg/L and a carotenoid in the manufacture of an infant formula for reducing obesity later in life, wherein the infant formula is indicated for administration to an infant in need thereof in the first year of life, wherein the infant formula has an energy content of less than 650 Kcal/L.
Patent NZ-705366-A (NZ)
Title: Method, computer program, and computer program product for controlling the milking by a milking device, and a milking arrangement
Inventor: BAHLENBERG PETER
IPC: A01J5/007
Filed: 2013-10-30
Abstract: A method for controlling the milking by a milking device comprises to provide (31) probability values for different milking parameter settings capable of being used for the milking of a milk producing animal; to draw (32) a milking parameter setting among the different milking parameter settings based on the probability values for the different milking parameter settings; to control (33) a milking of the milk producing animal such that the drawn milking parameter setting is used during the milking; to fetch (34) a sensed milk flow from the milk producing animal during the milking; to update (35) the probability values for the different milking parameter settings based on the fetched sensed milk flow; to draw (32) a further milking parameter setting among the different milking parameter settings based on the updated probability values for the different milking parameter settings; and to control (33) a following milking of the milk producing animal such that the drawn further milking parameter setting is used during the following milking. Such a method may allow optimised milk production, in terms of accuracy, precision, efficiency and reliability, as well as improved animal treatment.
Patent NZ-709545-A (NZ)
Title: Method for controlling a sluice drive for a sluice, said sluice drive having an electrical machine, operating circuit, sluice drive, and water power plant
Inventor: JANSSEN ANDREAS
IPC: H02P9/46
Filed: 2013-12-18
Abstract: The present invention address the problem of controlling a water sluice gate drive in the event of insufficient power supply. The present invention provides a method for controlling a water sluice gate drive for a water sluice gate wherein the drive has an electric machine, characterized in that the electric machine, has a fan brake, wherein the method comprises the following steps:  disengagement of the fan brake in the event that an insufficient power supply is indicated,  self-actuated operation of the electric machine, wherein the electric machine, is operated in generative island operation in which a rotating field is generated in a self-actuating manner.
Patent NZ-713809-A (NZ)
Title: 3,4-dihydroisoquinolin-2(1h)-yl compounds
Inventor: COATES DAVID
IPC: C07D217/16
Filed: 2014-05-27
Abstract: The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula (I), and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula (I) to treat cognitive impairment associated with Parkinson’s disease or schizophrenia.
Patent NZ-716860-A (NZ)
Title: Methods and compositions for generating epicardium cells
Inventor: KELLER GORDON
IPC: G01N33/50
Filed: 2014-09-12
Abstract: Provided are methods and products for obtaining cardiovascular lineage cells from hPSCs. The method for obtaining a cardiomyocyte lineage or an epicardial lineage cell population from human pluripotent stem cells (hPSCs) comprises one or more of the following steps: (a) contacting BMP component primed hPSCs with a cardiovascular mesoderm programming cocktail suitable for inducing the hPSCs to differentiate to a cardiovascular mesoderm cell population under conditions suitable for the programming cocktail to penetrate the hPSCs and culturing the contacted hPSCs for a period of time to generate a KDR+ and PDGFRalpha+ cardiovascular mesoderm cell population; (b) contacting the cardiovascular mesoderm cell population with a cardiovascular progenitor specification cocktail suitable to specify a NKX2-5+ or WT1+ cardiovascular progenitor cell population under conditions suitable for the specification cocktail to penetrate the cardiovascular mesoderm cell population and culturing the contacted cardiovascular mesoderm cell population for a period of time to generate a NKX2-5+ or WT1+ cardiovascular progenitor cell population; and (d) contacting the cardiovascular progenitor cell population with a maturation cocktail under conditions suitable for the maturation cocktail to penetrate the cardiovascular progenitor cell population and culturing the contacted cardiovascular progenitor population for a period of time to produce a cardiovascular population optionally cardiomyocyte lineage cells expressing cardiac troponin T (cTnT) and/or SIRPA and/or epicardial lineage cells expressing WT1. In a particular embodiment of the invention is an ex-vivo method of specifying a Wilm’s tumor protein 1 positive (WT1+) population comprising the step of contacting an hPSC-derived KDR+ and PDGFRalpha+ cardiovascular mesoderm cell population with a cardiovascular progenitor specification cocktail comprising human BMP4 at a concentration of between 0.63 ng/ml and 10 ng/ml. In addition this method optionally includes i) causing the cell population to progress toward a vascular smooth muscle-like fate by treating it with human TGFβ-1 or human TGFβ-1 followed by human bFGF; or (ii) causing the cell population to progress toward a fibroblast-like fate by treating it with human bFGF.
Patent NZ-726356-A (NZ)
Title: Processes for preparing antiviral compounds
Inventor: SARMA KESHAB
IPC: C07D491/052
Filed: 2015-06-08
Abstract: The present disclosure provides processes for the preparation of a compound of formula: which is useful as an antiviral agent. The disclosure also provides compounds that are synthetic intermediates.
Patent NZ-732970-A (NZ)
Title: Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
Inventor: KOVACEVICH BRIAN ROBERT
IPC: A61P27/02
Filed: 2012-05-21
Abstract: Disclosed is a method of inhibiting photophobia or light aversion or precluding the onset of photophobia or photoaversion in a subject in need thereof comprising administering an effective amount of an anti-CGRP antibody or antibody fragment, anti-CGRP receptor antibody or fragment, or a polypeptide comprising a fragment of CGRP or a CGRP receptor, wherein the antibody or antibody fragment or fragment of CGRP or CGRP receptor reduces or prevents CGRP-associated photophobia or light aversion.
Patent NZ-735636-A (NZ)
Title: Patient interface with blowout prevention for seal-forming portion
Inventor: SCHEINER RUPERT
IPC: A61M16/06
Filed: 2016-03-24
Abstract: One form of the present technology includes a sealing structure to seal against a user’s face around the user’s airways. The invention involves a patient interface (and an associated assembly thereof) that comprises a plenum chamber with a plenum chamber inner port, a sealing structure configured to contact and seal against a patient’s face and is bonded to the plenum chamber, a positioning and stabilising structure having a decoupling feature which prevents the sealing structure to break seal and a washout vent structure configured to allow a continuous vent flow. The sealing structure includes a flap or membrane that extends inward towards the user’s airways and includes a structure that prevents an inner boundary of the flap or membrane from being blown outwards (e.g., folded backwards upon itself) due to internal pressurization.
Patent NZ-741809-A (NZ)
Title: Compositions for the treatment of rheumatoid arthritis and methods of using same
Inventor: HUANG XIAOHONG
IPC: A61K39/395
Filed: 2012-10-10
Abstract: The disclosure relates to a method of treating rheumatoid arthritis in a subject previously treated by administering methotrexate, leflunomide, sulfasalazine and/or hydroxychloroquine, comprising administering to the subject an effective amount of sarilumab (SAR153191). The subject may have been treated with an anti-TNF-a antagonist for at least 3 months in the last 2 years or the subject may have been intolerant to at least one TNF-a antagonist.
Patent NZ-745047-A (NZ)
Title: Determining prediction parameters for non-square blocks in video coding
Inventor: KARCZEWICZ MARTA
IPC: H04N19/176
Filed: 2017-03-21
Abstract: Methods and apparatus for encoding and decoding video data comprising receiving a block of video data encoded using a position dependent intra prediction combination (PDPC) mode, the block of video data having a non-square shape defined by a width and a height, determining one or more horizontally-related PDPC parameters from a second lookup table using a first index retrieved from a first lookup table based on the width of the block and determining one or more vertically-related PDPC parameters from the second lookup table using a second index retrieved from the first lookup table based on the height of the block, and encoding or decoding the block of video data using the PDPC mode and the determined PDPC parameters.
Patent PT-105494-A (PT)
Title: Máquina para detectar, em antecipação, a libertação de urina e gerar o respectivo alarme
Inventor: CASQUEIRO JOAO PAULO RAFAEL
IPC: A61B5/00
Filed: 2011-01-20
Abstract: O PRESENTE INVENTO REFERE-SE A UM EQUIPAMENTO ELECTRÓNICO PARA DETECTAR, EM ANTECIPAÇÃO, A LIBERTAÇÃO DE URINA E GERAR O RESPECTIVO ALARME, DISPENSANDO A UTILIZAÇÃO DAS TRADICIONAIS FRALDAS, SEJA EM BÉBÉS OU EM INCONTINENTES, SENDO CONSTITUÍDO POR UM CINTO (1) QUE INCORPORA SENSORES BIOMÉTRICOS (2 E 3) E ELECTRÓNICA ASSOCIADA (4) QUE PERMITEM GERAR ALARMÍSTICA PARA TELEMÓVEIS OU RECEPTORES SEM FIOS (5, 6 E 7) ANTES DE HAVER LIBERTAÇÃO DE URINA, PERMITINDO, ASSIM, A ACÇÃO ATEMPADA POR PARTE DE PAIS OU PRESTADORES DE SAÚDE. A POUPANÇA EM FRALDAS, AS VANTAGENS PARA O MEIO AMBIENTE, O AUMENTO NA AUTO-ESTIMA DOS INCONTINENTES E O AUTO-CONDICIONAMENTO DOS BÉBÉS QUE OS LEVA A TORNAREM-SE AUTÓNOMOS MAIS CEDO, SÃO VANTAGENS IMPORTANTES DESTE INVENTO.
Patent PT-106014-A (PT)
Title: Tomada mista
Inventor: DUARTE MARCO RENATO MARQUES
IPC: H01R9/05
Filed: 2011-11-22
Abstract: O PRESENTE INVENTO REFERE-SE A UMA GAMA DE TOMADAS MISTAS INOVADORA AO INTEGRAR UM MECANISMO DE RADIOTELEVISÃO DE DIMENSÕES REDUZIDAS QUE INCORPORA UM INOVADOR SISTEMA DE FIXAÇÃO RÁPIDA DE CABO COAXIAL QUE POSSIBILITA UMA INSTALAÇÃO FÁCIL NO MECANISMO RTV, EVITANDO O APERTO DE PARAFUSOS E RECURSO A FERRAMENTAS.ALÉM DESTA CARACTERÍSTICA, A CONCEPÇÃO DO LOCAL DE ENTRADA DO CABO COAXIAL PERMITE QUE O MESMO SEJA APLICADO APENAS COM O NÚCLEO (ALMA) DESNUDADO, SENDO O FUNDAMENTAL CONTACTO COM A MALHA GARANTIDO NO MOMENTO DA INSERÇÃO DO CABO COAXIAL POR UM ESPIGÃO EXISTENTE NO INTERIOR DO CANHÃO DE ENTRADA DESTE NO MECANISMO RTV.QUANTO À ASSEMBLAGEM DO MECANISMO, ESTA TAMBÉM INTEGRA SOLUÇÕES INOVADORAS POIS A MONTAGEM DA CARCAÇA DO MECANISMO RTV É CONSEGUIDA POR APERTO DE PARAFUSOS QUE GARANTEM NÃO SÓ A CORRECTA ACOMODAÇÃO DOS COMPONENTES NO SEU INTERIOR COMO O CONTACTO DA PLACA DE CIRCUITO IMPRESSO (PCB) COM A METALIZAÇÃO DE CONTACTO DE ENTRADA E CARCAÇA, EVITANDO ASSIM PONTOS DE SOLDADURA COMO ACONTECE NAS DEMAIS.
Patent PT-115970-A (PT)
Title: Processo biológico de produção de ácido xilónico
Inventor: MARIA TERESA FERREIRA CESÁRIO SMOLDERS
IPC: C12N1/22
Filed: 2019-12-12
Abstract: É OBJETO DA PRESENTE INVENÇÃO UM PROCESSO DE PRODUÇÃO POR VIA MICROBIOLÓGICA DE ÁCIDO XILÓNICO, O QUAL É UM ÁCIDO ORGÂNICO SUBSTITUTO DO ÁCIDO GLUCÓNICO EM MUITAS APLICAÇÕES, NOMEADAMENTE COMO AGENTE QUELANTE, AGENTE DISPERSANTE NA INDÚSTRIA DE CIMENTO, PRECURSOR NA OBTENÇÃO DE 1,2,4-BUTANOTRIOL, POLIAMIDAS E POLIÉSTERES, E AINDA NA INDÚSTRIA FARMACÊUTICA E NA PRODUÇÃO DE SOLVENTES, PRODUTOS ADESIVOS, CORANTES E TINTAS. A PRESENTE INVENÇÃO CONSISTE NO PROCESSO BIOLÓGICO DE PRODUÇÃO DE ÁCIDO XILÓNICO USANDO COMO SUBSTRATO XILOSE OU HIDROLISADOS LENHO-CELULÓSICOS E COMO BIOCATALISADOR UMA ESTIRPE DA ESPÉCIE BACTERIANA RECENTEMENTE RECLASSIFICADA COMO PARABURKHOLDERIA SACCHARI, ANTERIORMENTE BURKHOLDERIA SACCHARI, EM MEIO FERMENTATIVO SOB CONDIÇÕES CONTROLADAS, NUM ÚNICO PASSO REACIONAL, UTILIZANDO CÉLULAS LIVREMENTE SUSPENSAS NO MEIO E ATRAVÉS DA INJEÇÃO DE AR E NÃO DE OXIGÉNIO PURO.